TBRA
Vanguard Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-242,940
| Closed | -$9.65M | – | 4130 |
|
2016
Q3 | $9.65M | Sell |
242,940
-96,235
| -28% | -$3.82M | ﹤0.01% | 2707 |
|
2016
Q2 | $4.26M | Buy |
339,175
+19,125
| +6% | +$240K | ﹤0.01% | 3061 |
|
2016
Q1 | $2.62M | Buy |
320,050
+4,906
| +2% | +$40.1K | ﹤0.01% | 3275 |
|
2015
Q4 | $3.17M | Buy |
315,144
+7,709
| +3% | +$77.5K | ﹤0.01% | 3208 |
|
2015
Q3 | $2.97M | Buy |
307,435
+45,942
| +18% | +$444K | ﹤0.01% | 3202 |
|
2015
Q2 | $4.51M | Sell |
261,493
-305,558
| -54% | -$5.27M | ﹤0.01% | 3065 |
|
2015
Q1 | $691K | Buy |
567,051
+23,181
| +4% | +$28.2K | ﹤0.01% | 3735 |
|
2014
Q4 | $496K | Buy |
543,870
+585
| +0.1% | +$534 | ﹤0.01% | 3728 |
|
2014
Q3 | $614K | Buy |
543,285
+38,692
| +8% | +$43.7K | ﹤0.01% | 3658 |
|
2014
Q2 | $3.43M | Buy |
504,593
+422,253
| +513% | +$2.87M | ﹤0.01% | 3022 |
|
2014
Q1 | $1.03M | Buy |
82,340
+71,140
| +635% | +$891K | ﹤0.01% | 3451 |
|
2013
Q4 | $53K | Buy |
+11,200
| New | +$53K | ﹤0.01% | 3877 |
|